DSM-Firmenich (DSFIR.AS) Stock Price

DSM-Firmenich Price

Euronext·CLOSED
105.75
​
Market closed

Over the last 12 years DSM-Firmenich grew revenue by 0.2% annually, reaching 9.03 B EUR. Earnings per share have declined at 3.8% per year over the last 11 years. For DSM-Firmenich, the net margin of -12.0% is down versus 7.6% a few years ago. At today's price the dividend yield works out to roughly 1.00%. The consensus 12-month price target for DSM-Firmenich is 98.94 EUR, about 6.4% below where the stock trades today. Of 31 analysts, 23 rate the stock a buy — an overall Buy consensus.

DSM-Firmenich stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

DSM-Firmenich business model & stock analysis

DSM-Firmenich AG generates revenue through its four business segments. The Perfumery & Beauty division sells perfumery, fragrance ingredients, and personal care aromas to fragrance and cosmetics companies. The Taste, Texture & Health segment provides natural flavour and ingredient solutions for food and beverage manufacturers. The Health, Nutrition & Care division offers customized products containing vitamins, nutritional lipids, digestive enzymes, probiotics, and CBD to health and wellness brands. The Animal Nutrition & Health business delivers tailored products, solutions, and services for animal farming, including vitamins, animal proteins, carotenoids, and premixes, to agricultural and livestock companies. All segments operate globally, serving clients in the fragrance, food, health, and animal agriculture industries. The company's product portfolio includes natural ingredients, vitamins, and specialized formulations that address specific market needs across these sectors. Revenue is derived from the sale of these branded products and services to established industry players. The firm's focus on innovation in nutrition, health, and beauty drives demand for its specialized offerings. Its global presence ensures consistent market access across regions, supporting long-term revenue streams from diverse client bases. Products are sold directly to manufacturers and service providers within each target industry.

Frequently asked questions about DSM-Firmenich

Analysts currently set an average price target of 97.65 EUR for the DSM-Firmenich stock (median: 98.94 EUR), implying -8.5 % versus the latest price. The consensus is based on 31 analyst ratings.

31 analysts currently rate the DSM-Firmenich stock: 23 recommend buying, 6 holding and 2 selling. For 2026, analysts expect DSM-Firmenich to generate revenue of 9.28 B EUR and earnings per share of 3.76 EUR.

The DSM-Firmenich share (DSFIR.AS) is listed on 8 stock exchanges, including: London (0AC9.L), Frankfurt (ZX6.F), München (ZX6.MU), Düsseldorf (ZX6.DU), Hamburg (ZX6.HM), Wien (DSFI.VI), Amsterdam (DSFIR.AS).

The expected revenue of DSM-Firmenich is 9.28 B EUR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of DSM-Firmenich is 979.39 M EUR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of DSM-Firmenich is currently 28.14. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the DSM-Firmenich stock.

The price-to-sales ratio (P/S) of DSM-Firmenich is currently 2.97. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the DSM-Firmenich stock.

The Eulerpool Quality Score for DSM-Firmenich is 2/10.

The ISIN of DSM-Firmenich is CH1216478797. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of DSM-Firmenich is A3D2TK. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of DSM-Firmenich is DSFIR.AS. The ticker symbol is used to trade DSM-Firmenich shares on the stock exchange.

Fair ValueTerminal
103.64 EUR
Over-/UndervaluationTerminal
Fairly valued
Industry
Chemicals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Currency
EUR
Initial public offering
Apr 18, 2023
ISIN
CH1216478797
Cusip
H0245V108
Market capitalization
28.10 B EURLarge Cap
52-Week Range
PEG
-2.45
P/E ratio
P/Ee 2026
28.69
P/Ee 2027
25.68
P/Ee 2028
23.10
P/Ee 2029
19.90
P/Ee 2030
17.48
P/S
P/Se
2.97
EV/EBIT
43.89
P/B Ratio
1.54
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-4.67 %
Dividend
Dividend yield
1.00 %
Est. Dividend Yield
2.36 %
Payout Ratio
-25.62 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
3 years
Dividend not reduced since
1 year
Dividend increased since
1 year
Dividend withholding tax
35.00 %
Last updated Nov 1, 2026, 12:34 AM

DSM-Firmenich Peer Group

DSM-Firmenich Ticker

AMSTERDAM · DSFIR.ASDÜSSELDORF · ZX6.DUEURONEXT · DSFIR.ASFRANKFURT · ZX6.FHAMBURG · ZX6.HMLONDON · 0AC9.LMUNICH · ZX6.MUVIENNA · DSFI.VI

DSM-Firmenich FIGI

DSFIR:NA · BBG01F6K3S63DSFIREUR:EP · BBG01G92FBT7DSFIREUR:EZ · BBG01G92FBW3DSFIREUR:EO · BBG01G92FBX2DSFIREUR:X2 · BBG01G92FBY1DSFIREUR:XH · BBG01G92FC06DSFIREUR:XF · BBG01G92FC24DSFIREUR:XE · BBG01G92FC42DSFIREUR:XJ · BBG01G92FC51DSFIREUR:XL · BBG01G92FC60DSFIREUR:XG · BBG01G92FC79DSFIREUR:XO · BBG01G92FC88

All fundamentals and in-depth analysis of DSM-Firmenich

Our stock analysis for DSM-Firmenich stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of DSM-Firmenich. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.